NCT00003198View on ClinicalTrials.gov

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1997

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

ifosfamide

DRUG

topotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003198 - Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter